Alberto Bottini
- Cancer Research top 1%
- Breast Cancer Treatment Studies 50
- Oncology top 2%
- HER2/EGFR in Cancer Research 31
- Cancer Treatment and Pharmacology 30
-
- Breast Lesions and Carcinomas 10
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer 8
-
- Advanced Breast Cancer Therapies 13
-
- Estrogen and related hormone effects 14
-
- Neuroendocrine Tumor Research Advances 10
- Co-authors
- Daniele GeneraliAlfredo BerrutiLuigi DogliottiAdrian L. HarrisManuela MilaniSergio AgugginiStephen B. FoxGiovanni Allevi
- Journals
- Journal of Clinical Oncology (19 papers)Cancer Research (9 papers)British Journal of Cancer (8 papers)
- Partner nations
- ItalyUnited KingdomAustralia
In The Last Decade
Alberto Bottini
116 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 110
- Cancer Research 1.5k
- Oncology 1.6k
- Pathology and Forensic Medicine 368
- Molecular Biology 1.1k
- Pulmonary and Respiratory Medicine 510
Countries citing papers authored by Alberto Bottini
This map shows the geographic impact of Alberto Bottini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Bottini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Bottini more than expected).
Fields of papers citing papers by Alberto Bottini
This network shows the impact of papers produced by Alberto Bottini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Bottini. The network helps show where Alberto Bottini may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alberto Bottini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 3 | |
| 2 | 2019 | 51 | |
| 3 | 2016 | 4 | |
| 4 | 2016 | 8 | |
| 5 | 2015 | 6 | |
| 6 | 2013 | 57 | |
| 7 | 2013 | 38 | |
| 8 | 2011 | 5 | |
| 9 | 2010 | 17 | |
| 10 | 2009 | 129 | |
| 11 | 2009 | 255 | |
| 12 | Anti-proliferative effect of combining Letrozole with Sorafenib in MCF-7/Arom-1 breast cancer cells | 2008 | 1 |
| 13 | 2007 | 12 | |
| 14 | Factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients | 2006 | 6 |
| 15 | 2005 | 8 | |
| 16 | 2005 | 28 | |
| 17 | Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer. | 2002 | 41 |
| 18 | 2001 | 8 | |
| 19 | p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients. | 2000 | 103 |
| 20 | 1996 | 44 |
About Alberto Bottini
Alberto Bottini is a scholar working on Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 117 papers that have together received 3.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (50 papers), HER2/EGFR in Cancer Research (31 papers), Cancer Treatment and Pharmacology (30 papers), Estrogen and related hormone effects (14 papers), Advanced Breast Cancer Therapies (13 papers), Breast Lesions and Carcinomas (10 papers), Neuroendocrine Tumor Research Advances (10 papers) and PI3K/AKT/mTOR signaling in cancer (8 papers). The work is most often cited by research in Cancer Research (1.5k citations), Oncology (1.6k citations), Pathology and Forensic Medicine (368 citations), Molecular Biology (1.1k citations) and Pulmonary and Respiratory Medicine (510 citations). Alberto Bottini has collaborated with scholars based in Italy, United Kingdom and Australia. Frequent co-authors include Daniele Generali, Alfredo Berruti, Luigi Dogliotti, Adrian L. Harris, Manuela Milani, Sergio Aguggini, Stephen B. Fox, Giovanni Allevi, Maria Pia Brizzi and Alessandra Bersiga. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, British Journal of Cancer, Breast Cancer Research and Treatment and JNCI Monographs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.